Crispr Therapeutics shares owned by Voloridge Investment Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Voloridge Investment Management
from 13F filings
Historical chart of Voloridge Investment Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Voloridge Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Voloridge Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $46M | 727k | 62.60 |
| 2023-06-30 | $1.4M | 26k | 56.14 |
| 2023-03-31 | $3.0M | 66k | 45.23 |
| 2022-09-30 | $1.0M | 15k | 65.34 |
| 2022-06-30 | $9.0M | 148k | 60.77 |
| 2022-03-31 | $24M | 379k | 62.77 |
| 2021-12-31 | $16M | 216k | 75.78 |
| 2021-09-30 | $305k | 2.7k | 112.01 |
| 2021-06-30 | $742k | 4.6k | 161.90 |
| 2021-03-31 | $5.0M | 41k | 121.84 |
| 2020-12-31 | $4.5M | 29k | 153.10 |
| 2019-12-31 | $3.6M | 60k | 60.91 |
| 2018-12-31 | $1.8M | 63k | 28.57 |
More positions owned by Voloridge Investment Management
Block Cl A (SQ)
View all positions for Voloridge Investment Management